Benjamin L Maughan, Genitourinary Oncologist at Huntsman Cancer Institute, shared on X:
“Miguel Zugman presented interesting results KCRS 2025 – cabo seems equivalent to TKI/IO. Since there seems no immunologic synergy in the long-term f/u studies in RCC and other cancers, our patients deserve randomized data. with SAMETA and STELLAR closed please consider PAPMET2!”
Miguel Zugman, Postdoctoral fellow at City of Hope, shared Benjamin L Maughan’s post on X:
“Grateful for the highlight. Couldn’t agree more: papillary RCC needs randomized data. Let’s make PAPMET2 happen!”
More posts featuring Miguel Zugman and Benjamin Maughan.
